Comparison of Patient Satisfaction between Subcutaneous Immunotherapy and Sublingual Immunotherapy in Allergic Rhinitis
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background and Objectives Comparative clinical studies of sublingual and subcutaneous treatments have yielded heterogeneous results. In this study, we compared clinical outcomes in patients allergic to house dust mites (HDMs) that received at least 1 year of subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT). Subjects and Method The present study included 120 patients with HDM allergic rhinitis, 54 patients in the SCIT group and 66 patients in the SLIT group. Each patient was asked to answer a set of questionnaire before starting immunotherapy. The questionnaires included the rhinoconjunctivitis quality of life questionnaire (RQLQ) and a patient satisfaction questionnaire. The patients were asked to answer the questions after undergoing at least 1 year of immunotherapy. Results RQLQ scores collected after immunotherapy in both SCIT and SLIT groups were decreased significantly. However, the SCIT group had a significantly higher decrease in RQLQ scores for non-nose/eye symptoms than the SLIT group (p-value=0.015). There were no differences in other satisfaction scores between the two groups. SCIT improved clinical symptoms faster than SLIT did within 6 months and 1 year (p-value=0.011, p-value=0.045 respectively). Conclusion SCIT is more effective than SLIT in improving non-nose/eye symptoms in patients with allergic rhinitis. SCIT may relieve the symptoms faster than SLIT. Korean J Otorhinolaryngol-Head Neck Surg 2016;59(2):120-4
Abstract
Background and Objectives Comparative clinical studies of sublingual and subcutaneous treatments have yielded heterogeneous results. In this study, we compared clinical outcomes in patients allergic to house dust mites (HDMs) that received at least 1 year of subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT). Subjects and Method The present study included 120 patients with HDM allergic rhinitis, 54 patients in the SCIT group and 66 patients in the SLIT group. Each patient was asked to answer a set of questionnaire before starting immunotherapy. The questionnaires included the rhinoconjunctivitis quality of life questionnaire (RQLQ) and a patient satisfaction questionnaire. The patients were asked to answer the questions after undergoing at least 1 year of immunotherapy. Results RQLQ scores collected after immunotherapy in both SCIT and SLIT groups were decreased significantly. However, the SCIT group had a significantly higher decrease in RQLQ scores for non-nose/eye symptoms than the SLIT group (p-value=0.015). There were no differences in other satisfaction scores between the two groups. SCIT improved clinical symptoms faster than SLIT did within 6 months and 1 year (p-value=0.011, p-value=0.045 respectively). Conclusion SCIT is more effective than SLIT in improving non-nose/eye symptoms in patients with allergic rhinitis. SCIT may relieve the symptoms faster than SLIT. Korean J Otorhinolaryngol-Head Neck Surg 2016;59(2):120-4
참고문헌 (13)
- Akdis CA, "Allergy and hypersensitivity: mechanisms of allergic disease", Curr Opin Immunol, 18(6), pp.718~726 (2006)
- Brozek JL, "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision", J Allergy Clin Immunol, 126(3), pp.466~476 (2010)
- Akdis CA, "Mechanisms of allergen-specific immunotherapy", J Allergy Clin Immunol, 127(1), pp.18~27 (2011)
- Casale TB, "Immunotherapy: what lies beyond", J Allergy Clin Immunol, 133(3), pp.612~619 (2014)
- Calderón MA, "Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile", Allergy, 67(3), pp.302~311 (2012)
- Kleine-Tebbe J, "Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial", Allergy, 61(2), pp.181~184 (2006)
- Moingeon P, "Immune mechanisms of allergen-specific sublingual immunotherapy", Allergy, 61(2), pp.151~165 (2006)
- Quirino T, "Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study", Clin Exp Allergy, 26(11), pp.1253~1261 (1996)
- Khinchi MS, "Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study", Allergy, 59(1), pp.45~53 (2004)
- Saporta D, "Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients", J Environ Public Health, 2012, pp.492405~ (2012)
- 장현, "Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites", Clinical and Experimental Otorhinolaryngology, 2(3), pp.136~140 (2009), 대한이비인후과학회
- Juniper EF, "Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire", J Allergy Clin Immunol, 104(2 Pt 1), pp.364~369 (1999)
- 박기환, "통년성 알레르기비염 환자의 삶의 질 평가를 위한 설문지- 제 1 보 -", 대한이비인후과학회지 두경부외과학, 45(3), pp.254~262 (2002), 대한이비인후과학회